Financials
- Market Capitalization 456.43 M
- Employee 71
- Founded 2010
- CEO N/A
- Website www.rezolutebio.com
- Headquarter Nevada, United States
- FIGI BBG001XWWHL4
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-4.55
Relación precio/flujo de caja
—
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2974 | PRTA Prothena Corporation plc - Ordinary Shares | 8.83 USD | -4.44% | -8.21% | +0.68% | +37.11% | 462.28 M USD | ||
| 2977 | STRO Sutro Biopharma, Inc. - Common Stock | 27.84 USD | -6.36% | -10.19% | -3.33% | +60.09% | 461.32 M USD | ||
| 2986 | VALN Valneva SE - American Depositary Shares | 5.26 USD | +4.16% | -0.75% | -3.84% | -19.45% | 456.41 M USD | ||
| 2991 | OVID Ovid Therapeutics Inc. - Common Stock | 2.43 USD | -3.57% | -7.25% | +7.05% | +507.50% | 453.54 M USD |